Matches in Wikidata for { <http://www.wikidata.org/entity/Q92168882> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q92168882 description "artículu científicu espublizáu n'avientu de 2019" @default.
- Q92168882 description "im Dezember 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q92168882 description "scientific article published on 19 December 2019" @default.
- Q92168882 description "wetenschappelijk artikel" @default.
- Q92168882 description "наукова стаття, опублікована 19 грудня 2019" @default.
- Q92168882 name "Cancer immunotherapy with immunoadjuvants, nanoparticles, and checkpoint inhibitors: Recent progress and challenges in treatment and tracking response to immunotherapy" @default.
- Q92168882 name "Cancer immunotherapy with immunoadjuvants, nanoparticles, and checkpoint inhibitors: Recent progress and challenges in treatment and tracking response to immunotherapy" @default.
- Q92168882 type Item @default.
- Q92168882 label "Cancer immunotherapy with immunoadjuvants, nanoparticles, and checkpoint inhibitors: Recent progress and challenges in treatment and tracking response to immunotherapy" @default.
- Q92168882 label "Cancer immunotherapy with immunoadjuvants, nanoparticles, and checkpoint inhibitors: Recent progress and challenges in treatment and tracking response to immunotherapy" @default.
- Q92168882 prefLabel "Cancer immunotherapy with immunoadjuvants, nanoparticles, and checkpoint inhibitors: Recent progress and challenges in treatment and tracking response to immunotherapy" @default.
- Q92168882 prefLabel "Cancer immunotherapy with immunoadjuvants, nanoparticles, and checkpoint inhibitors: Recent progress and challenges in treatment and tracking response to immunotherapy" @default.
- Q92168882 P1433 Q92168882-0A745A7C-A081-4320-B1FE-8DAEFA43CE62 @default.
- Q92168882 P1476 Q92168882-C770CBB9-31E1-4036-9F1A-CC113A211279 @default.
- Q92168882 P2093 Q92168882-00067719-6711-4763-9330-6EFB46BF3AE7 @default.
- Q92168882 P2093 Q92168882-D9096841-6763-49DB-AF71-6F7A0DA98F2F @default.
- Q92168882 P2860 Q92168882-33176831-2A47-4E7B-8E39-E5183F87A7B8 @default.
- Q92168882 P304 Q92168882-EC2AFED8-E699-4E37-84C6-6BCA15C27102 @default.
- Q92168882 P31 Q92168882-4CC93B26-EF64-4FE9-A317-00598340E01E @default.
- Q92168882 P31 Q92168882-75042721-0341-4a9e-8ee8-f8dbfec61b90 @default.
- Q92168882 P356 Q92168882-367C7356-1D2B-4559-962D-1AB36AAAB9FE @default.
- Q92168882 P478 Q92168882-919B38E9-91F8-4750-9DB7-62EBC3915AE5 @default.
- Q92168882 P577 Q92168882-11FF7C2C-7A99-4085-A92A-A98C9F014F4E @default.
- Q92168882 P698 Q92168882-3A769753-A6C1-44FC-A376-6B3FB10D6933 @default.
- Q92168882 P921 Q92168882-106B0F68-0467-4AE0-BCC5-FF6D65F16EEC @default.
- Q92168882 P932 Q92168882-D401FF44-EB41-47D5-A4B0-A50ECDA616D9 @default.
- Q92168882 P356 J.PHARMTHERA.2019.107456 @default.
- Q92168882 P698 31863820 @default.
- Q92168882 P1433 Q3378596 @default.
- Q92168882 P1476 "Cancer immunotherapy with immunoadjuvants, nanoparticles, and checkpoint inhibitors: Recent progress and challenges in treatment and tracking response to immunotherapy" @default.
- Q92168882 P2093 "Ashish Ranjan" @default.
- Q92168882 P2093 "Michael-Joseph Gorbet" @default.
- Q92168882 P2860 Q28214264 @default.
- Q92168882 P304 "107456" @default.
- Q92168882 P31 Q13442814 @default.
- Q92168882 P31 Q7318358 @default.
- Q92168882 P356 "10.1016/J.PHARMTHERA.2019.107456" @default.
- Q92168882 P478 "207" @default.
- Q92168882 P577 "2019-12-19T00:00:00Z" @default.
- Q92168882 P698 "31863820" @default.
- Q92168882 P921 Q1427096 @default.
- Q92168882 P932 "7039751" @default.